Cigna Group

For the period ended Dec 31, 2024. Filed Feb 27, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 27, 2025

CI$295.60+0.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Earnings Per Share

Note 6 – Earnings Per Share

Accounting Policy. The Company computes basic earnings per share using the weighted-average number of unrestricted common and deferred shares outstanding. Diluted earnings per share also includes the dilutive effect of outstanding employee stock options and restricted stock using the treasury stock method and the effect of strategic performance shares.

Basic and diluted earnings per share were computed as follows:

	For the Years Ended December 31,
2024 · 2023 · 2022
(Shares in thousands, dollars in millions, except per share amounts) · Basic · Effect ofDilution · Diluted · Basic · Effect ofDilution · Diluted · Basic · Effect ofDilution · Diluted
Shareholders' net income	$3,434			$3,434		$5,164				$5,164		$6,704		$6,704
Shares:
Weighted average	280,294			280,294		293,892				293,892		309,546		309,546
Common stock equivalents		2,924		2,924				2,990		2,990			3,519	3,519
Total shares	280,294		2,924		283,218		293,892		2,990		296,882		309,546	3,519	313,065
Earnings per share	$12.25		$(0.13)		$12.12		$17.57		$(0.18)		$17.39		$21.66	$(0.25)	$21.41

The following outstanding employee stock options were not included in the computation of diluted earnings per share because their effect was anti-dilutive:

	For the Years Ended December 31,
(In millions)	2024	2023	2022
Anti-dilutive options	1.1	0.9	1.0

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.